Fresenius Kabi to purchase Fenwal
05:04 EDT 23 Jul 2012 | Medical Business Review
Fresenius Kabi has entered into a definitive agreement to purchase Fenwal, a provider of separation technologies for blood and cell collection and therapy.
Original Article: Fresenius Kabi to purchase Fenwal
More From BioPortfolio on "Fresenius Kabi to purchase Fenwal"
Biotech & Healthcare Channels
World News
Life Science Events
Corporate Database
Market Reports
Categories
Search BioPortfolio:
